phenyl acetate has been researched along with Age-Related Memory Disorders in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (13.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 5 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Adebayo, OG; Aduema, W; Ajibo, DN; Akpotu, AE; Ben-Azu, B; Ebo, OT; Kolawole, TA; Onuoha, OG; Onyeleonu, I; Umoren, EB; Wopara, I | 1 |
| Bonato, JM; Chinen, LY; Comar, JF; de Oliveira, DV; de Oliveira, RMW; de Paula, MN; de Sa-Nakanishi, AB; Godinho, J; Mello, JCP; Milani, H; Neves Pereira, OC; Previdelli, IS | 1 |
| Aigner, L; Altendorfer, B; Attems, J; Chishty, M; Felder, T; Garnweidner-Raith, J; Holztrattner, M; Hutter-Paier, B; Johnson, M; Leister, I; Marschallinger, J; Masliah, E; Pillichshammer, N; Rockenstein, E; Strempfl, K; Unger, MS | 1 |
| Aluko, OM; Umukoro, S | 1 |
| Cui, J; Li, H; Li, J; Liu, J; Wu, D; Xu, G | 1 |
| Solomon, U; Taghogho, EA | 1 |
| Aluko, OM; Annafi, OS; Eduviere, AT; Omorogbe, O; Umukoro, S | 1 |
| Baek, SJ; Heo, S; Jung, J; Kim, BC; Kim, DH; Kwon, H; Lee, S; Lee, YC; Park, HJ; Park, SJ; Ryu, JH; Yi, JH | 1 |
| Chin, YW; Cho, J; Moniruzzaman, M | 1 |
| Hong, H; Hu, M; Kong, LY; Lai, J; Li, JC; Long, Y; Miao, MX; Wang, H; Wang, XB | 1 |
| Adeoluwa, OA; Aluko, OM; Eduviere, AT; Omogbiya, IA; Umukoro, S | 1 |
| Gibbs, ME; Gibbs, Z; Hertz, L | 1 |
| Koudinov, AR; Koudinova, NV | 1 |
| Stegink, AJ | 1 |
| Vojtĕchovský, M | 1 |
2 trial(s) available for phenyl acetate and Age-Related Memory Disorders
| Article | Year |
|---|---|
The clinical use of piracetam, a new nootropic drug. The treatment of symptoms of senile involution.
Topics: Acetamides; Acetates; Adult; Aged; Amides; Asthenia; Clinical Trials as Topic; Dementia; Depression; Headache; Humans; Hypochondriasis; Memory Disorders; Middle Aged; Perceptual Disorders; Placebos; Psychomotor Disorders; Pyrrolidinones; Sleep Wake Disorders; Vertigo | 1972 |
[Modification of memory disturbances after electroshock with centrophenoxine].
Topics: Acetates; Adult; Chronic Disease; Clinical Trials as Topic; Electroshock; Humans; Meclofenoxate; Memory Disorders; Placebos; Psychological Tests; Schizophrenia; Stimulation, Chemical; Word Association Tests | 1970 |
13 other study(ies) available for phenyl acetate and Age-Related Memory Disorders
| Article | Year |
|---|---|
Lead acetate induces hippocampal pyramidal neuron degeneration in mice via up-regulation of executioner caspase-3, oxido-inflammatory stress expression and decreased BDNF and cholinergic activity: Reversal effects of Gingko biloba supplement.
Topics: Acetates; Acetylcholinesterase; Animals; Brain-Derived Neurotrophic Factor; Caspase 3; Cholinergic Agents; Ginkgo biloba; Hippocampus; Lead; Male; Memory Disorders; Mice; Nerve Degeneration; Oxidative Stress; Pyramidal Cells; Up-Regulation | 2022 |
Delayed administration of Trichilia catigua A. Juss. Ethyl-acetate fraction after cerebral ischemia prevents spatial memory deficits, decreases oxidative stress, and impacts neural plasticity in rats.
Topics: Acetates; Animals; Brain Ischemia; Brain-Derived Neurotrophic Factor; Cerebral Infarction; Glutathione Disulfide; Hippocampus; Meliaceae; Memory Disorders; Neuronal Plasticity; Neuroprotective Agents; Oxidative Stress; Plant Extracts; Rats; Superoxide Dismutase | 2023 |
The Leukotriene Receptor Antagonist Montelukast Reduces Alpha-Synuclein Load and Restores Memory in an Animal Model of Dementia with Lewy Bodies.
Topics: Acetates; alpha-Synuclein; Animals; Cyclopropanes; Disease Models, Animal; Female; Humans; Leukotriene Antagonists; Lewy Body Disease; Memory; Memory Disorders; Mice; Mice, Transgenic; Quinolines; Receptors, Leukotriene; Sulfides | 2020 |
Methyl jasmonate reverses chronic stress-induced memory dysfunctions through modulation of monoaminergic neurotransmission, antioxidant defense system, and Nrf2 expressions.
Topics: Acetates; Animals; Antioxidants; Biogenic Monoamines; Brain; Cyclopentanes; Dose-Response Relationship, Drug; Gene Expression; Male; Memory Disorders; NF-E2-Related Factor 2; Oxylipins; Plant Growth Regulators; Rats; Rats, Wistar; Stress, Psychological; Synaptic Transmission | 2020 |
Effects of ethyl acetate extract from Coreopsis tinctoria on learning and memory impairment in d-galactose-induced aging mice and the underlying molecular mechanism.
Topics: Acetates; Aging; Animals; Coreopsis; Disease Models, Animal; Galactose; Hippocampus; Male; Maze Learning; Memory; Memory Disorders; Mice; Mice, Inbred ICR; Oxidative Stress; Plant Extracts | 2021 |
Methyl jasmonate attenuates memory dysfunction and decreases brain levels of biomarkers of neuroinflammation induced by lipopolysaccharide in mice.
Topics: Acetates; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents; Astrocytes; Biomarkers; Brain; Cyclooxygenase 2; Cyclopentanes; Inflammation; Interleukin-1beta; Lipopolysaccharides; Male; Maze Learning; Memory; Memory Disorders; Mice; Microglia; Neuroimmunomodulation; NF-kappa B; Nitric Oxide Synthase Type II; Oxylipins; Prefrontal Cortex; Tumor Necrosis Factor-alpha | 2017 |
Probable mechanisms involved in the antipsychotic-like activity of methyl jasmonate in mice.
Topics: Acetates; Animals; Antioxidants; Antipsychotic Agents; Brain; Bromocriptine; Cyclopentanes; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Ketamine; Locomotion; Male; Maze Learning; Memory; Memory Disorders; Mice; Oxidative Stress; Oxylipins; Psychotic Disorders; Stereotyped Behavior; Time Factors | 2017 |
Direct pharmacological Akt activation rescues Alzheimer's disease like memory impairments and aberrant synaptic plasticity.
Topics: Acetates; Alzheimer Disease; Amyloid beta-Peptides; Animals; Avoidance Learning; Benzofurans; Benzopyrans; Disease Models, Animal; Enzyme Inhibitors; Evoked Potentials; Gene Expression Regulation; Hippocampus; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neuronal Plasticity; Oligopeptides; Oncogene Protein v-akt; Oxadiazoles; Peptide Fragments; Reaction Time; Recognition, Psychology | 2018 |
HO-1 dependent antioxidant effects of ethyl acetate fraction from Physalis alkekengi fruit ameliorates scopolamine-induced cognitive impairments.
Topics: Acetates; Animals; Antioxidants; Cell Line; Cognitive Dysfunction; Fruit; Glucosides; Heme Oxygenase-1; Luteolin; Male; MAP Kinase Signaling System; Memory Disorders; Mice, Inbred ICR; Physalis; Proto-Oncogene Proteins c-akt; Scopolamine | 2018 |
Montelukast targeting the cysteinyl leukotriene receptor 1 ameliorates Aβ1-42-induced memory impairment and neuroinflammatory and apoptotic responses in mice.
Topics: Acetates; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Caspase 3; Cerebral Cortex; Cyclopropanes; Cytokines; Hippocampus; Leukotriene Antagonists; Male; Maze Learning; Memory Disorders; Mice; Mice, Inbred ICR; Neuroprotective Agents; NF-kappa B; Nootropic Agents; Peptide Fragments; Proto-Oncogene Proteins c-bcl-2; Quinolines; Receptors, Leukotriene; Sulfides | 2014 |
Possible Mechanisms Involved in Attenuation of Lipopolysaccharide-Induced Memory Deficits by Methyl Jasmonate in Mice.
Topics: Acetates; Acetylcholinesterase; Animals; Brain; Cyclopentanes; Lipopolysaccharides; Memory Disorders; Mice; Neuroprotective Agents; Nitrites; Oxidative Stress; Oxylipins; Recognition, Psychology | 2016 |
Rescue of Abeta(1-42)-induced memory impairment in day-old chick by facilitation of astrocytic oxidative metabolism: implications for Alzheimer's disease.
Topics: 3-Hydroxybutyric Acid; Acetates; Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Newborn; Astrocytes; Caprylates; Chickens; Citric Acid Cycle; Discrimination Learning; Glucose; Hypoglycemic Agents; Insulin; Ketone Bodies; Lactic Acid; Memory Disorders; Oxidation-Reduction; Peptide Fragments; Reinforcement, Psychology | 2009 |
Cholesterol, synaptic function and Alzheimer's disease.
Topics: Acetates; Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Cholesterol; Disease Models, Animal; Electric Stimulation; Humans; Immunohistochemistry; In Vitro Techniques; Learning Disabilities; Long-Term Potentiation; Memory Disorders; Nerve Degeneration; Neurodegenerative Diseases; Rats; Rats, Wistar; Risk Factors; Synapses; Synaptic Transmission; Tritium | 2003 |